Table A1.
Patient demographic and clinical data.
| Characteristic | n (%) |
|---|---|
| Age, years (mean, ±SD 1) | 56.3 (44.8–67.8) |
| Gender: | |
| Female | 28 (40.0%) |
| Male | 42 (60.0%) |
| BMI 2, kg/m2 | 27 (25–32) |
| <30 kg/m2 | 34 (48.6%) |
| ≥30 kg/m2 | 23 (32.8%) |
| Unknown | 13 (18.6%) |
| PAH 3 | |
| Yes | 36 (51.4%) |
| No | 34 (48.6%) |
| DM2 4 | |
| Yes | 17 (24.3%) |
| No | 53 (75.7%) |
| Alcohol abuse | |
| Yes | 21 (30.0%) |
| No | 49 (70.0%) |
| Possible route of HCV 5 infection | |
| Blood transfusion | 19 (27.4%) |
| IV drug abuse | 19 (27.4%) |
| Tattoo | 15 (21.4%) |
| Surgical intervention | 2 (2.8%) |
| Unknown | 13 (21.0%) |
| HCV genotype | |
| 1 | 46 (65.7%) |
| 2 | 4 (5.7%) |
| 3 | 18 (25.7%) |
| HAI 6 | |
| 4–8 | 55 (94.8%) |
| 9–12 | 3 (5.2%) |
| METAVIR | 8 (11.4%) |
| F3 F4 | 62 (88.6%) |
| Degree of steatosis (liver bioptate, median) | 20% (7.0–30.0) |
| History of interferon-based treatment | |
| No | 51 (72.9%) |
| Yes | 19 (27.1%) |
1 SD—standard deviation; 2 BMI—body mass index; 3 PAH—primary arterial hypertension; 4 DM2—diabetes mellitus type 2; 5 HCV—hepatitis C virus; 6 HAI—histology activity index.